Abstract
ObjectivesIn most European countries, innovative medical devices are not managed according to cost–utility methods, the reason being that national agencies do not generally evaluate these products. The objective of our...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have